Literature DB >> 18252714

Toll-like receptor 4 mediates induction of the Bcl10-NFkappaB-interleukin-8 inflammatory pathway by carrageenan in human intestinal epithelial cells.

Sumit Bhattacharyya1, Ravinder Gill, Mei Ling Chen, Fuming Zhang, Robert J Linhardt, Pradeep K Dudeja, Joanne K Tobacman.   

Abstract

The sulfated polysaccharide carrageenan (CGN) induces activation of NFkappaB and interleukin 8 (IL-8) in human colonic epithelial cells through a pathway of innate immunity mediated by Bcl10 (B-cell CLL/lymphoma 10). In this report, we identify Toll-like receptor 4 (TLR4), a member of the family of innate immune receptors, as the surface membrane receptor for CGN in human colonic epithelial cells. Experiments with fluorescence-tagged CGN demonstrated a marked reduction in binding of CGN to human intestinal epithelial cells and to RAW 264.7 mouse macrophages, following exposure to TLR4 blocking antibody (HTA-125). Binding of CGN to 10ScNCr/23 mouse macrophages, which are deficient in the genetic locus for TLR4, was absent. Additional experiments with TLR4 blocking antibody and TLR4 small interfering RNAs showed 80% reductions in CGN-induced increases in Bcl10 and IL-8. Transfection with dominant-negative MyD88 plasmid demonstrated MyD88 dependence of the CGN-TLR4-triggered increases in Bcl10 and IL-8. Therefore, these results indicate that CGN-induced inflammation in human colonocytes proceeds through a pathway of innate immunity, perhaps related to the unusual alpha-1,3-galactosidic linkage characteristic of CGN, and suggest how dietary CGN intake may contribute to human intestinal inflammation. Because CGN is a commonly used food additive in the Western diet, clarification of its effects and mechanisms of action are vital to issues of food safety.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18252714      PMCID: PMC2447641          DOI: 10.1074/jbc.M708833200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4.

Authors:  Loïc Guillot; Samir Medjane; Karine Le-Barillec; Viviane Balloy; Claire Danel; Michel Chignard; Mustapha Si-Tahar
Journal:  J Biol Chem       Date:  2003-11-04       Impact factor: 5.157

2.  NCM460, a normal human colon mucosal epithelial cell line.

Authors:  M P Moyer; L A Manzano; R L Merriman; J S Stauffer; L R Tanzer
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-06       Impact factor: 2.416

Review 3.  Transgenic approaches for the reduction of Galalpha(1,3)Gal for xenotransplantation.

Authors:  M S Sandrin; N Osman; I F McKenzie
Journal:  Front Biosci       Date:  1997-04-01

4.  Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2.

Authors:  R Schwandner; R Dziarski; H Wesche; M Rothe; C J Kirschning
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

5.  Combined transgenic expression of alpha-galactosidase and alpha1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Galalpha(1,3)Gal.

Authors:  N Osman; I F McKenzie; K Ostenried; Y A Ioannou; R J Desnick; M S Sandrin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

6.  Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.

Authors:  Yong-Han Paik; Robert F Schwabe; Ramón Bataller; Maria P Russo; Christian Jobin; David A Brenner
Journal:  Hepatology       Date:  2003-05       Impact factor: 17.425

7.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

8.  Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).

Authors:  Q Zhang; R Siebert; M Yan; B Hinzmann; X Cui; L Xue; K M Rakestraw; C W Naeve; G Beckmann; D D Weisenburger; W G Sanger; H Nowotny; M Vesely; E Callet-Bauchu; G Salles; V M Dixit; A Rosenthal; B Schlegelberger; S W Morris
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

9.  Preparation and properties of fluorescent polysaccharides.

Authors:  C G Glabe; P K Harty; S D Rosen
Journal:  Anal Biochem       Date:  1983-04-15       Impact factor: 3.365

10.  Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells.

Authors:  Mathias W Hornef; Birgitta Henriques Normark; Alain Vandewalle; Staffan Normark
Journal:  J Exp Med       Date:  2003-10-20       Impact factor: 14.307

View more
  63 in total

1.  Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity.

Authors:  Juan Manuel Torres; Rubén Martinez-Barricarte; Sonia García-Gómez; Marina S Mazariegos; Yuval Itan; Bertrand Boisson; Rita Rholvarez; Anaïs Jiménez-Reinoso; Lucia del Pino; Rebeca Rodríguez-Pena; Antonio Ferreira; Enrique Hernández-Jiménez; Victor Toledano; Carolina Cubillos-Zapata; Mariana Díaz-Almirón; Eduardo López-Collazo; José L Unzueta-Roch; Silvia Sánchez-Ramón; Jose R Regueiro; Eduardo López-Granados; Jean-Laurent Casanova; Rebeca Pérez de Diego
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

2.  Interactions of estradiol and NSAIDS on carrageenan-induced hyperalgesia.

Authors:  Deirtra A Hunter; Gordon A Barr; Kai-Yvonne Shivers; Nicole Amador; Shirzad Jenab; Charles Inturrisi; Vanya Quinones-Jenab
Journal:  Brain Res       Date:  2011-01-31       Impact factor: 3.252

3.  Exposure to the common food additive carrageenan leads to glucose intolerance, insulin resistance and inhibition of insulin signalling in HepG2 cells and C57BL/6J mice.

Authors:  S Bhattacharyya; I O-Sullivan; S Katyal; T Unterman; J K Tobacman
Journal:  Diabetologia       Date:  2011-10-20       Impact factor: 10.122

4.  Increased expression of colonic Wnt9A through Sp1-mediated transcriptional effects involving arylsulfatase B, chondroitin 4-sulfate, and galectin-3.

Authors:  Sumit Bhattacharyya; Leo Feferman; Joanne K Tobacman
Journal:  J Biol Chem       Date:  2014-04-28       Impact factor: 5.157

5.  Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-κB pathway in vitro.

Authors:  Wenping Wang; Tingsong Xia; Xinpu Yu
Journal:  Inflamm Res       Date:  2015-04-28       Impact factor: 4.575

6.  Carrageenan-induced NFkappaB activation depends on distinct pathways mediated by reactive oxygen species and Hsp27 or by Bcl10.

Authors:  Sumit Bhattacharyya; Pradeep K Dudeja; Joanne K Tobacman
Journal:  Biochim Biophys Acta       Date:  2008-04-11

7.  Niacin inhibits carrageenan-induced neutrophil migration in mice.

Authors:  Raphael Gomes Ferreira; Tamires Cardoso Matsui; Lindisley Ferreira Gomides; Adriana Martins Godin; Gustavo Batista Menezes; Márcio de Matos Coelho; André Klein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-03-26       Impact factor: 3.000

8.  Characterization of protein tyrosine phosphatase H1 knockout mice in animal models of local and systemic inflammation.

Authors:  Claudia Patrignani; David T Lafont; Valeria Muzio; Béatrice Gréco; Rob Hooft van Huijsduijnen; Paola F Zaratin
Journal:  J Inflamm (Lond)       Date:  2010-03-30       Impact factor: 4.981

Review 9.  Future directions in cancer prevention.

Authors:  Asad Umar; Barbara K Dunn; Peter Greenwald
Journal:  Nat Rev Cancer       Date:  2012-11-15       Impact factor: 60.716

10.  Degraded carrageenan causing colitis in rats induces TNF secretion and ICAM-1 upregulation in monocytes through NF-kappaB activation.

Authors:  Claudine Benard; Antonietta Cultrone; Catherine Michel; Carlos Rosales; Jean-Pierre Segain; Marc Lahaye; Jean-Paul Galmiche; Christine Cherbut; Hervé M Blottière
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.